Canadian Cancer Trials Group Bulletins

Trial Management Group


RIPPLE - Next Wave of Trials Moving into RIPPLE

In April 2014, the entire Canadian roster as well as the MA.32 Participants Lists (PL) was moved into RIPPLE. Recently, the following new trials were also added in RIPPLE:
  • BR.31
  • PRC.4
  • IND.214
  • ME.11 (activation pending)

On December 11, 2014, the next wave of open trials will be moved into RIPPLE and includes:
  • ALC.3
  • BL.12
  • BRC.5
  • CEC.1
  • CRC.6
  • CRC.7
  • CX.5
  • HEC.1
  • LYC.1
  • MA.32F
  • MA.33
  • MAC.14
  • MAC.15
  • MEC.3
  • PR.13
  • PRC.3
  • SRC.6
  • IND.208
  • IND.209
  • IND.210
  • IND.211
  • IND.213
  • IND.215

PLEASE NOTE: BLC.1, PR.15 AND CO.21 WILL NO LONGER BE MOVING INTO RIPPLE.

All QIs and PCRAs at centres participating on those trials moving to RIPPLE will receive several memos that will include additional details before December 11.

Finally, all Canadian centres should anticipate that the majority of new trials will use RIPPLE. The trial Central Activation Letter will specify if a new trial is using RIPPLE or paper Participants Lists.

If you have any questions, please email ripple@ctg.queensu.ca.